CHINA SXT PHARMACEUTICALS IN (SXTC)

VGG2161P1403 - Common Stock

0.9787  +0.02 (+1.89%)

After market: 0.9993 +0.02 (+2.1%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2023
(2023-3-31)
2022
(2022-3-31)
2021
(2021-3-31)
2020
(2020-3-31)
Revenue
1.70M1.97M2.60M4.78M5.16M
Cost Of Goods
1.08M1.55M1.35M1.94M2.46M
Gross Profit
628.34K430.00K1.25M2.84M2.70M
Operating Expenses
14.43M5.68M6.44M5.03M4.04M
Selling, General, and Administrative Expenses
14.43M5.68M6.44M5.04M4.04M
Operating Income
-13.81M-5.26M-5.19M-2.20M-1.34M
Interest Income/Expense
-426.52K-480.00K-40.00K-1.62M-3.35M
Other Income/Expense
99.38K150.00K-180.00K870.00K-70.00K
Non Recurring Items
N/A-350.00K0.000.00-5.63M
Income Before Taxes
-14.14M-5.93M-5.41M-2.94M-10.39M
Income Tax
N/A0.00330.00K-190.00K-100.00K
Net Income
-14.14M-5.93M-5.74M-2.75M-10.29M
EBITDA
-13.57M-5.01M-4.87M-1.85M-1.01M
 
Per Share Data
EPS Diluted Total Ops
-29.66-21.96-143.50-91.66-1.03K
 
Statistics
Gross Profit Margin
36.97%21.83%48.08%59.41%52.33%
Profit Margin
-831.74%-301.02%-220.77%-57.53%-199.42%
Operating Profit Margin
-812.50%-267.01%-199.62%-46.03%-25.97%

All data in USD

Charts